Back to Our Insights
Spotlight on Japan

Spotlight on Japan

As the world’s second-largest pharma and medtech market, Japan has historically been an innovation center for the industry. But amid an evolving healthcare landscape, this collection of articles and interviews looks at what opportunities and challenges executives at life-sciences companies need to address.

Our Insights

Article

Understanding the opportunity in Japan’s biosimilar market
– Despite a sluggish start, Japan’s biosimilar market looks set for accelerated growth. The country’s patient co-pay dynamic, financial... incentives, and commercial model will be keys to success.
Article

The rise and rise of medtech in Asia
– How can medtech companies thrive in the world’s fastest-growing market?
Article

Change in the Japanese pharmaceutical market: Cradle of innovation or grave of corporate profits?
– Understanding structural shifts in the market can help pharma stakeholders innovate and, ultimately, deliver benefits for patients.
Article

A more effective model for managing change in Japan could accelerate economic growth
– A culturally attuned approach is required.
Article

Asia on the move: Five trends shaping the Asia biopharmaceutical market
– Enthusiasm for the biopharmaceutical sector in Asia has been flat, due in part to China’s market-access blockade, Japan’s... spending controls, and deceleration in India and Southeast Asia. Recent changes have reignited interest in the region, with important implications for pharma executives.
Article

The evolving role of medical affairs in Asia−Pacific: Three imperatives for pharmacos
– Medical affairs is poised for a broader, more strategic role. However, leaders will need to ramp up new types of capabilities... and talent to achieve this ambition.
Article

The digital imperative for pharma companies in Japan
– Five facts showing that companies should invest in digital customer engagement in Japan.
Article

The medtech opportunity for Japanese companies
– A large-scale commitment to growth in healthcare technologies could be a key contributor to the Japanese economy.
Article

Elevating the impact of medical affairs in Japan
– Recent research sheds light on the value of the medical channel and what it takes to have a high-performing medical-affairs organization.

External Voices

Interview

Building digital ecosystems in Japan
– Two Merck Healthcare digital specialists explain their company’s transformation and the impact it has had on patients.
Interview

Leading change in the Japanese pharma market: Innovating for the future in an uncertain present
– Jacques Nathan, president of Sanofi Japan, discusses what’s ahead for his changing sector.
Interview

What’s next for Japan’s pharma market
– The president of Merck in Japan discusses how healthcare players in the country can capitalize on early detection rates and use... collaboration to drive innovation.
Interview

From semiconductors to life sciences: Building a global business out of Japan
– The president and CEO of JSR Corporation discusses the company’s plans to grow a global healthcare franchise building from... his lessons in the semiconductor industry.